Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiotypic network in myasthenia gravis.

H Eng1, A K Lefvert

  • 1Department of Medicine, Karolinska Hospital, Stockholm, Sweden.

Clinical and Experimental Rheumatology
|September 1, 1989
PubMed
Summary

Levels of idiotypic and anti-idiotypic antibodies (Ab) in myasthenia gravis patients fluctuated inversely or in relation to each other. Similar B cell repertoire specificities were observed in affected and healthy twins.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast.

Clinical pharmacology and therapeutics·2016
Same author

Monoclonal anti-torpedo receptor antibodies used to study antibody heterogeneity in myasthenic sera.

Neurochemistry international·2010
Same author

Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor.

Xenobiotica; the fate of foreign compounds in biological systems·2010
Same author

Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis.

Journal of internal medicine·2007
Same author

Human Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activation.

Scandinavian journal of immunology·2007
Same author

Treatment of a patient with myasthenia gravis using antibodies against CD25.

Acta neurologica Scandinavica·2007

Area of Science:

  • Immunology
  • Autoimmune Diseases

Background:

  • Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
  • Understanding the dynamics of antibody (Ab) production in MG is crucial for disease management.

Observation:

  • Idiotype and anti-idiotype Ab levels were monitored over time in two MG patients.
  • A twin study compared an MG patient with her healthy twin, analyzing B cell repertoire specificities.

Findings:

  • Fluctuations in idiotype and anti-idiotype Ab levels showed inverse or related patterns in MG patients.
  • Both twins, despite one having MG, exhibited similar Ab specificities and immunoglobulin specificities in their B cell repertoire.

Implications:

  • The findings suggest complex regulatory interactions between idiotypic and anti-idiotypic antibodies in myasthenia gravis.
  • The similarity in B cell repertoires between affected and healthy twins may indicate a predisposition or early-stage molecular events in MG pathogenesis.

Related Experiment Videos